Marc H. Hedrick's most recent trade in Plus Therapeutics Inc was a trade of 5,748,506 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 5,748,506 | 5,748,506 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 1,916,168 | 1,916,168 | - | - | Restricted Stock Units | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 400,489 | 400,489 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 197,595 | 197,595 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 10 Sep 2024 | 8,000 | 20,425 (0%) | 0% | 1.2 | 9,839 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 24,510 | 24,510 | - | - | Warrants (Right to buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 08 May 2024 | 12,255 | 12,425 (0%) | 0% | 2.0 | 25,000 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 94,012 | 94,012 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Hedrick Marc H. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.96 per share. | 20 Nov 2023 | 2,068 | 170 (0%) | 0% | 2.0 | 4,053 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 483,824 | 483,824 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 15 Jun 2022 | 5,000 | 33,580 (0%) | 0% | 0.6 | 3,240 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.68 per share. | 27 Apr 2022 | 2,500 | 28,580 (0%) | 0% | 0.7 | 1,710 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 26 Apr 2022 | 5,000 | 26,080 (0%) | 0% | 0.7 | 3,450 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.66 per share. | 26 Oct 2021 | 2,500 | 21,080 (0%) | 0% | 1.7 | 4,150 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 200,771 | 200,771 | - | - | Stock Option (right to buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 30 Apr 2021 | 2,183 | 18,580 (0%) | 0% | 2.3 | 4,970 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 04 Mar 2021 | 2,500 | 16,397 (0%) | 0% | 2.5 | 6,250 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 88,314 | 88,314 | - | - | Stock Option (right to buy) | |
| Plus Therapeutics Inc | Marc H. Hedrick | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 10 Dec 2020 | 2,500 | 13,867 (0%) | 0% | 2.0 | 4,975 | Common Stock |
| Plus Therapeutics Inc | Marc H. Hedrick | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 30 Nov 2020 | 2,200 | 11,367 (0%) | 0% | 2.1 | 4,708 | Common Stock |